GlassScriptPhysician profile
Adam Jared Stoller
NPI 1699913178
$5,932.27
in general payments reported to CMS, 2019-2025
39 companies · $364 in 2025
The $364 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,162 · 2020: $1,469 · 2021: $967 · 2022: $633 · 2023: $177 · 2024: $160 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $701.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,801.92 | 2019-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $617.99 | 2019-2022 | |
| Stimwave Technologies Incorporated | $315.78 | 2019 | |
| Collegium Pharmaceutical, INC. | $263.12 | 2019-2023 | Belbuca |
| Abbvie INC. | $199.09 | 2019-2024 | Botox |
| Electronic Waveform Lab, INC. | $160.65 | 2019-2023 | |
| Relievant Medsystems, INC. | $158.28 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $124.14 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $117.63 | 2019-2021 | |
| Mml US, INC. | $97.60 | 2025 | Reactiv8 |
| Nevro Corp. | $86.40 | 2020-2023 | Senza |
| Scilex Pharmaceuticals INC. | $85.17 | 2019-2020 | |
| Mdd US Operations, LLC | $72.91 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $63.78 | 2021 | |
| Stryker Corporation | $62.18 | 2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.81 | 2019-2025 | Relistor |
| Vertex Pharmaceuticals Incorporated | $59.11 | 2025 | |
| Amgen INC. | $58.94 | 2019 | |
| Novartis Pharmaceuticals Corporation | $55.62 | 2019-2020 | |
| Spr Therapeutics, INC | $48.59 | 2019-2022 | |
| Saluda Medical Americas, INC. | $47.23 | 2024 | Evoke |
| Pfizer INC. | $30.57 | 2019 | |
| Allergan, INC. | $29.99 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $28.71 | 2022 | |
| Almatica Pharma LLC | $28.37 | 2021 | |
| Depuy Synthes Sales INC. | $26.30 | 2021 | |
| Convatec INC. | $26.20 | 2025 | |
| Fidia Pharma USA INC. | $24.93 | 2025 | Hymovis |
| Flowonix Medical Incorporated | $23.36 | 2019 | |
| Nalu Medical, INC. | $22.94 | 2022 | |
| Arbor Pharmaceuticals, INC. | $19.52 | 2021 | |
| Assertio Therapeutics, INC. | $18.86 | 2019 | |
| Horizon Therapeutics Plc | $18.80 | 2020 | |
| Si-Bone, INC. | $15.55 | 2024 | |
| Kaleo, INC. | $12.63 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.61 | 2019 | |
| Forte Bio-Pharma LLC | $12.60 | 2021 | |
| Shionogi INC | $12.28 | 2019 | |
| Lilly USA, LLC | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Stoller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.